Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Table 2 from Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors
  1. Home
  2. Publications
  3. Table 2 from Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors

Table 2 from Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors

Authors:
  • VMVicky Makker
    Vicky Makker
  • JLJung-Yun Lee
    Jung-Yun Lee
  • DODo-Youn Oh
    Do-Youn Oh
  • AOAna Oaknin
    Ana Oaknin
  • SPSoham Puvvada
    Soham Puvvada
  • LJLindsey Jung
    Lindsey Jung
  • RMRobert McEwen
    Robert McEwen
  • FMFlavia Michelini
    Flavia Michelini
  • FMFunda Meric-Bernstam
    Funda Meric-Bernstam

Open Access
Publisher website
Google Scholar
  • 1 July 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.32845444
Abstract
Concordancea rates between local and central HER2 test results and tumor type/cohort.
Keywords
  • IHC CONCORDANCE
  • IHC STATUS
  • POST HOC
  • HOC ANALYSIS
  • TRASTUZUMAB DERUXTECAN
  • DERUXTECAN EFFICACY
  • SOLID TUMORS
  • TUMORS CONCORDANCEA
  • CONCORDANCEA RATES
  • TUMOR TYPE
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.